SCHEMBL7552030

SCHEMBL7552030

CCOC(=O)c1ccc(Oc2ccccc2C(=N)N)nc1Oc1ccccc1C(=N)N

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 8/20 0.63
F2 P00734 2/20 0.47
TSHR P16473 1/20 0.47
ALDH1A1 P00352 2/20 0.45
HSD17B10 Q99714 1/20 0.45
CDC25B P30305 2/20 0.42
CYP1A2 P05177 3/20 0.41
CYP2C9 P11712 3/20 0.41
CYP2C19 P33261 3/20 0.41
POLB P06746 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALK Q9UM73 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
CYP2D6 P10635 1/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP3A4 P08684 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TBXAS1 P24557 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7408094 0.81 F10 (0.61) F10F2
SCHEMBL7404047 0.81 F10 (0.61) F10F2
SCHEMBL6581300 0.77 F10 (1.00) F10F2
SCHEMBL10943608 0.76 TSHR (0.75) TSHRALDH1A1HSD17B10CDC25BL3MBTL1
Hydrochloric Acid SCHEMBL9617120 0.74 TSHR (0.72) TSHRALDH1A1HSD17B10CDC25BL3MBTL1
SCHEMBL7555146 0.73 F10 (0.78) F10F2KDM4E
SCHEMBL28974979 0.73 TSHR (0.74) TSHRALDH1A1HSD17B10CDC25BCYP1A2
SCHEMBL8339299 0.71 F10 (0.61) F10F2ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL25866271 0.70 TSHR (0.47) F10TSHRALDH1A1HSD17B10CDC25B
Diethyl Phthalate SCHEMBL27603722 0.69 TSHR (0.88) TSHRALDH1A1HSD17B10CDC25BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020035109-A1 Benzamidine derivatives and their use as anti-coagulants BERLEX LABORATORIES, INC. 2002-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035109-A1 Benzamidine derivatives and their use as anti-coagulants SERPINC1, HABP2, SERPINE1 F10 49/4885F2 4/4885TSHR 3838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.